Eugenia Kharlampieva - University of Alabama at Birmingham
Parissa Heshmati, PhD - Evonik Corporation
This 2-part session will describe the advancement of drug and gene delivery technologies that can help overcome limitations of getting an active pharmaceutical agent in the body at the right place, at the right dose, at the right time. It will highlight the efforts of local companies and university scientists to increase efficacy of new drugs while limiting potential side effects, all while manipulating delivery systems at the nanoscale.
Part I: After a big picture overview of the field of drug and gene delivery technologies, Evonik Corporation will highlight its capabilities to encapsulate very potent active pharmaceuticals in micro- and nano-particles composed of biodegradable polymers, which allows a single injection to have a lasting therapeutic effect of weeks or months.
A collaborative team, at the University of Alabama at Birmingham, will present how they are developing microcapsules with for example cancer- or diabetes-fighting properties, using layer by layer techniques and hydrogels.
You are invited to a Zoom webinar.
When: Oct 6, 2020 03:45 PM Central Time (US and Canada)
Topic: PART I Good Things in Small Packages - Drug and Gene Delivery in the Age of Nanotechnology
Please click the link below to join the webinar:
https://us02web.zoom.us/j/84691702491
Or iPhone one-tap :
US: +13017158592,,84691702491# or +13126266799,,84691702491#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 301 715 8592 or +1 312 626 6799 or +1 929 205 6099 or +1 253 215 8782 or +1 346 248 7799 or +1 669 900 6833
Webinar ID: 846 9170 2491
International numbers available: https://us02web.zoom.us/u/kMWYuKwO
This 2-part session will describe the advancement of drug and gene delivery technologies that can help overcome limitations of getting an active pharmaceutical agent in the body at the right place, at the right dose, at the right time. It will highlight the efforts of local companies and university scientists to increase efficacy of new drugs while limiting potential side effects, all while manipulating delivery systems at the nanoscale.